Common Contracts
8 similar Underwriting Agreement contracts by Global Medical REIT Inc., Physicians Realty Trust
GLOBAL MEDICAL REIT INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 12th, 2019 • Global Medical REIT Inc. • Real estate investment trusts • New York
7,250,000 Shares GLOBAL MEDICAL REIT INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 14th, 2019 • Global Medical REIT Inc. • Real estate investment trusts • New York
Global Medical REIT Inc., a Maryland corporation (the “Company”), together with Global Medical REIT L.P., a Delaware limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), and Inter-American Management LLC, a Delaware limited liability company (the “Manager”), agrees with Stifel, Nicolaus & Company, Incorporated, BMO Capital Markets Corp., Robert W. Baird & Co. Incorporated, KeyBanc Capital Markets Inc. and SunTrust Robinson Humphrey, Inc., as the representatives (collectively, the “Representatives”) of the several Underwriters named in Schedule A hereto (collectively, the “Underwriters”), to issue and sell to the several Underwriters 7,250,000 shares (the “Firm Securities”) of its common stock, par value $0.001 per share (the “Securities”), and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 1,087,500 additional Securities (the “Optional Securities”) as set forth
3,500,000 Shares GLOBAL MEDICAL REIT INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 12th, 2018 • Global Medical REIT Inc. • Real estate investment trusts • New York
Global Medical REIT Inc., a Maryland corporation (the “Company”), together with Global Medical REIT L.P., a Delaware limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), and Inter-American Management LLC, a Delaware limited liability company (the “Manager”), agrees with Stifel, Nicolaus & Company, Incorporated (“Stifel”) and BMO Capital Markets Corp. (“BMO”), as the representatives (the “Representatives”) of the several Underwriters named in Schedule A hereto (collectively, the “Underwriters”), to issue and sell to the several Underwriters 3,500,000 shares (the “Firm Securities”) of its common stock, par value $0.001 per share (the “Securities”), and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 525,000 additional Securities (the “Optional Securities”) as set forth below. The Firm Securities and the Optional Securities are herein collectively called the “Offer
2,700,000 Shares GLOBAL MEDICAL REIT INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 14th, 2017 • Global Medical REIT Inc. • Real estate investment trusts • New York
3,500,000 Shares GLOBAL MEDICAL REIT INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2017 • Global Medical REIT Inc. • Real estate investment trusts • New York
13,043,479 Shares GLOBAL MEDICAL REIT INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 5th, 2016 • Global Medical REIT Inc. • Real estate investment trusts • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2016 • Global Medical REIT Inc. • Real estate investment trusts • New York
] Common Shares PHYSICIANS REALTY TRUST Common Shares of Beneficial Interest UNDERWRITING AGREEMENTUnderwriting Agreement • December 2nd, 2013 • Physicians Realty Trust • Real estate investment trusts • New York
Physicians Realty Trust, a Maryland real estate investment trust (the “Company”), agrees with Wunderlich Securities, Inc. (the “Representative”) as the representative of the several Underwriters named in Schedule A hereto (collectively, the “Underwriters”) to issue and sell to the several Underwriters [ ] shares (the “Firm Securities”) of its common shares of beneficial interest, par value $0.01 per share (the “Securities”), and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than [ ] additional shares of its Securities (the “Optional Securities”) as set forth below. The Firm Securities and the Optional Securities are herein collectively called the “Offered Securities.” Upon receipt of the net proceeds of (a) the sale of the Firm Securities on the First Closing Date (as defined below) and (b) any and all Optional Securities on each Optional Closing Date (as defined below), the Company will contribute such net proceeds to
